According to the latest report by IMARC Group, titled, “Biopharmaceutical Third Party Logistics (3PL) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global biopharmaceutical third party logistics (3PL) market size reached US$ 109.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 154.2 Billion by 2027, exhibiting a growth rate (CAGR) of 5.8% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
%20Market.jpg "Biopharmaceutical Third Party Logistics (3PL) Market")
Biopharmaceutical third party logistics (3PL) refers to the transportation of medicines using advanced vehicles. These vehicles are specially designed to automate temperature and reduce the possibility of human errors during transportation. Biopharmaceutical 3PL helps carry various medical products, maintain inventory of the goods and fulfill orders. It also minimizes overhead expenses, ensures uninterrupted product supply and improves the transportation services of an organization.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/biopharmaceutical-third-party-logistics-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Biopharmaceutical Third Party Logistics (3PL) Market Trends:
The rising demand for effective logistics systems to safely transport temperature-sensitive medicines is one of the key factors driving the growth of the global biopharmaceutical 3PL market. Furthermore, the emerging trend of outsourcing logistics by medical organizations to optimize their distribution network is propelling market growth. As coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs. Moreover, various technological advancements and growing environmental concerns among pharmaceutical companies to reduce carbon footprint are creating a positive outlook for the market.
Competitive Landscape:
- Agility Logistics
- AmerisourceBergen Corporation
- DB Schenker (Deutsche Bahn)
- DHL International GmbH (Deutsche Post)
- FedEx Corporation
- Kerry Logistics Network Limited
- Kuehne + Nagel International AG
- McKesson Corporation
- SF Express Co. Ltd.
- United Parcel Service of America Inc.
For more information about this report visit: https://www.imarcgroup.com/biopharmaceutical-third-party-logistics-market
The report has segmented the market on the basis of Product Type, Distribution Channel, Packaging Type and Region.
Breakup by Supply Chain:
- Cold Chain
- Non-Cold Chain
Breakup by Service Type:
- Transportation
- Air Freight
- Sea Freight
- Overland
- Warehousing and Storage
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
